Education and Training
Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection
To compare the positivity rate of the investigational assay to the currently approved QuantiFERON-TB Gold In-Tube assay.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- device: CST001
- device: CST001
Eligibility
Low Risk and Known Risk Cohorts
Inclusion Criteria:
- Compensated and uncompensated members (current or future) of the Department of
Veterans Affairs with no identified symptoms of active TB disease
- Age greater than 18 years or less than 80 years.
Exclusion Criteria:
- Currently taking therapy for active tuberculosis or latent TB infection for more than
14 days.
Ages Eligible for Study
18 Years - 80 Years
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Mark Holodniy, MD
650-852-3408
Not Recruiting